Someday, Constellation Software (Constellation Software Stock Quote, Chart, News: TSX:CSU) will stop going up, but that won’t happen in 2015, says one portfolio manager.
Jason Donville, President & CEO at Donville Kent Asset Management was on BNN’s Market Call yesterday and revealed his top picks. Kent says Constellation, which has risen from under forty dollars in 2010 to a closing price yesterday of $376.15, will continue to rise on the back of what it has repeatedly demonstrated to be its real expertise: buying other companies.
“My expectation is that it’s going to be another great year of acquisitions for Constellation,” said Donville.
Citing a recent debt financing, Donville says he thinks Constellation might be ready to make a big move.
“If you don’t think you are going to be acquiring something why would you be raising debt right now?,” he asked, rhetorically. “What they are signalling to the market by doing their debt deal back in autumn is that they think they are going to have a use of capital because they are brilliant capital allocators. The last thing they want to do is be overcapitalized by taking on a bunch of money they can’t employ.”
While the analyst consensus on Constellation is that the stock is a “Hold”, Donville thinks that take will be proven to be too pessimistic.
“My guess is that by the end of the year they will have beaten the current year’s estimates by a good ten to fifteen per cent,” he said.
Donville’s other top picks are Valeant Pharmaceuticals (Valeant Pharmaceuticals Stock Quote, Chart, News: TSX:VRX) and CGI Group (CGI Group Stock Quote, Chart, News: TSX:GIB.A).
Canada’s labour market has softened sharply since the start of the year, with the unemployment rate reaching 7% in May,… [Read More]
Count RBC Capital Markets analyst Ken Herbert among the believers in MDA (MDA Stock Quote, Chart, News, Analysts, Financials TSX:MDA).… [Read More]
Roth Capital Markets analyst Suji Desilva said in a July 3 report that Netlist (Netlist Stock Quote, Chart, News, Analysts,… [Read More]
Research Capital analyst Andre Uddin is recommending Theratechnologies (Theratechnologies Stock Quote, Chart, News, Analysts, Financials NASDAQ:THTX) shareholders tender their shares… [Read More]
Haywood Capital Markets analyst Gianluca Tucci reiterated a “Buy” rating on KITS Eyecare (KITS Eyecare Stock Quote, Chart, News, Analysts,… [Read More]
Roth Capital Markets analyst Suji Desilva maintained a “Buy” rating and US$18.00 target on D-Wave Quantum (D-Wave Quantum Stock Quote,… [Read More]